Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. WAR /
  3. CTX.WAR

Captor Therapeutics S.A. (CTX WAR) stock market data APIs

zł77 -1.8(-2.3%) as of July 26, 2024
Price chart is built with Anychart

Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. It has various therapeutic molecules in the preclinical stage. The company was incorporated in 2015 and is headquartered in Wroclaw, Poland.

Captor Therapeutics S.A. Financial Data Overview

78.8
77
-
79
76.6
59-141
358 M
4 646 K
16 163 K
-2.4724
0.606
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'CTX',
Type: 'Common Stock',
Name: 'Captor Therapeutics S.A.',
Exchange: 'WAR',
CurrencyCode: 'PLN',
CurrencyName: 'Polish złoty',
CurrencySymbol: 'zł',
CountryName: 'Poland',
CountryISO: 'PL',
OpenFigi: NULL,
ISIN: 'PLCPTRT00014',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

Captor Therapeutics S.A. Fundamental Data is available in our Financial Data APIs

  • Net Revenue 16 163 K
  • EBITDA -62 338 000
  • Earnings Per Share -13.85
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Captor Therapeutics S.A. Earnings via APIs

  • Latest Release 2024-04-09
  • EPS/Forecast NaN

Get Captor Therapeutics S.A. End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Captor Therapeutics S.A. latest news via APIs

Captor Therapeutics Publishes Q1 2023 Financial Results

Lead asset CT-01 on track for clinical trial application authorization in Q3 2023 Collaboration with Ono Pharmaceuticals in neurological diseases progressing according to planSolid cash position allow...
  • CAPTOR THERAPEUTICS
  • EARNINGS RELEASES AND OPERATING RESULTS
  • WARSAW STOCK EXCHANGE:CTX

Captor Therapeutics Discloses Molecular Targets of Pipeline’s Lead Assets and Invites Stakeholders to Webcast

CT-01 targets 3 well suited proteins including NEK7 with poor prognosis in key liver cancer Strong preclinical data generated with CT-02 against NEK7CT-05 potential best-in-class profile in high poten...
  • CAPTOR THERAPEUTICS
  • CONFERENCE CALLS/ WEBCASTS
  • WARSAW STOCK EXCHANGE:CTX
Do you have any questions?
support@eodhistoricaldata.com